{"nct_id":"NCT02472145","title":"An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2015-08-04","start_date_type":"ACTUAL","primary_completion_date":"2018-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2018-01-25","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["JNJ"]}